Sanjeev Aggarwal - Nov 23, 2021 Form 4 Insider Report for EVERSPIN TECHNOLOGIES INC (MRAM)

Signature
/s/ Anthony Griff, Attorney-in-fact for Sanjeev Aggarwal
Stock symbol
MRAM
Transactions as of
Nov 23, 2021
Transactions value $
-$251,708
Form type
4
Date filed
11/24/2021, 03:10 PM
Previous filing
Nov 18, 2021
Next filing
Nov 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRAM Common Stock Sale -$2.47K -218 -0.59% $11.32 36.9K Nov 23, 2021 Direct F1
transaction MRAM Common Stock Options Exercise $83.6K +9.17K +24.87% $9.12 46K Nov 23, 2021 Direct
transaction MRAM Common Stock Options Exercise $75.2K +11.8K +25.74% $6.35 57.9K Nov 23, 2021 Direct
transaction MRAM Common Stock Options Exercise $164K +24.8K +42.79% $6.63 82.6K Nov 23, 2021 Direct
transaction MRAM Common Stock Sale -$572K -45.8K -55.4% $12.50 36.9K Nov 23, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRAM Employee Stock Option (Right to Buy) Options Exercise $0 -9.17K -91.66% $0.00 834 Nov 23, 2021 Common Stock 9.17K $9.12 Direct F3
transaction MRAM Employee Stock Option (Right to Buy) Options Exercise $0 -11.8K -59.25% $0.00 8.15K Nov 23, 2021 Common Stock 11.8K $6.35 Direct F4
transaction MRAM Employee Stock Option (Right to Buy) Options Exercise $0 -24.8K -100% $0.00* 0 Nov 23, 2021 Common Stock 24.8K $6.63 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold solely to pay taxes due upon the vesting of restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.50 to $12.54, inclusive. The reporting person undertakes to provide to Everspin Technologies, Inc.'s (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
F3 1/4th of the shares subject to the option vested on March 13, 2019 and 1/36th of the remaining shares are scheduled to vest in successive equal monthly installments thereafter.
F4 1/4th of the shares subject to the option vested on February 11, 2020 and 1/36th of the remaining shares are scheduled to vest in successive equal monthly installments thereafter.
F5 1/4th of the shares subject to the option vested on April 26, 2017 and 1/36th of the remaining shares vested in successive equal monthly installments thereafter.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney